Relay Therapeutics’ combination therapy slows breast cancer progression in early trial

Relay Therapeutics said on Monday that interim data from an early trial of its combination breast cancer drug showed it significantly increased patients' life expectancy without worsening the course of…

Continue ReadingRelay Therapeutics’ combination therapy slows breast cancer progression in early trial